Associations - AR mutation

BIOMARKER:

AR mutation

Entrez ID:

Related biomarkers:

‹

›

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

AR mutation AR mutation	Prostate Cancer Prostate Cancer	PCM-075 Sensitive: C3 – Early Trials PCM-075 Sensitive : C3
AR mutation AR mutation	Prostate Cancer Prostate Cancer	abiraterone acetate + GDC-0068 Resistant: C3 – Early Trials abiraterone acetate + GDC-0068 Resistant : C3
AR mutation AR mutation	Prostate Cancer Prostate Cancer	enzalutamide Resistant: C3 – Early Trials enzalutamide Resistant : C3
AR mutation AR mutation	Prostate Cancer Prostate Cancer	abiraterone acetate Resistant: C3 – Early Trials abiraterone acetate Resistant : C3
AR mutation AR mutation	Prostate Cancer Prostate Cancer	CPI-0209 Sensitive: D – Preclinical CPI-0209 Sensitive : D